73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Researchers synthesize chimeric peptide that elicits antitumor activity for cancer immunotherapy

Researchers synthesize chimeric peptide that elicits antitumor activity for cancer immunotherapy

by Science China PressThepeptide Pal-DMPOP consists a peptide inhibitor of CD47/SIRPα, a D-peptide inhibitor of PD-1/PD-L1, and a palmitic acid tail conjugated at its N-terminal through a P

Researchers synthesize chimeric peptide that elicits antitumor activity for cancer immunotherapy

by Science China PressThepeptide Pal-DMPOP consists a peptide inhibitor of CD47/SIRPα, a D-peptide inhibitor of PD-1/PD-L1, and a palmitic acid tail conjugated at its N-terminal through a P
Immune landscape and response to oncolytic virus-based immunotherapy

Immune landscape and response to oncolytic virus-based immunotherapy

by Frontiers JournalsCredit:Frontiers of Medicine(2024). DOI: 10.1007/s11684-023-1048-0Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, of

Immune landscape and response to oncolytic virus-based immunotherapy

by Frontiers JournalsCredit:Frontiers of Medicine(2024). DOI: 10.1007/s11684-023-1048-0Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, of
Genetically engineered dendritic cells enhance the power of immunotherapy against lung cancer

Genetically engineered dendritic cells enhance the power of immunotherapy against lung cancer

by Denise Heady,University of California, Los AngelesGraphical Abstract. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2024.101479A study by researchers at the UCLA Health

Genetically engineered dendritic cells enhance the power of immunotherapy against lung cancer

by Denise Heady,University of California, Los AngelesGraphical Abstract. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2024.101479A study by researchers at the UCLA Health
Exercise may help reduce long-term side effects of chemotherapy for breast cancer patients

Exercise may help reduce long-term side effects of chemotherapy for breast cancer patients

by University of AmsterdamCredit: CC0 Public DomainAfter treatment for breast cancer, most women suffer side effects such as fatigue, not feeling physically fit and cognitive issues. This can oft

Exercise may help reduce long-term side effects of chemotherapy for breast cancer patients

by University of AmsterdamCredit: CC0 Public DomainAfter treatment for breast cancer, most women suffer side effects such as fatigue, not feeling physically fit and cognitive issues. This can oft
Survey finds one in three patients needed more information on cancer treatment side effects

Survey finds one in three patients needed more information on cancer treatment side effects

by American Society for Radiation OncologyIn a nationwide survey of US adults treated for cancer, 1 in 3 patients said they experienced side effects from cancer treatment that they wish they'

Survey finds one in three patients needed more information on cancer treatment side effects

by American Society for Radiation OncologyIn a nationwide survey of US adults treated for cancer, 1 in 3 patients said they experienced side effects from cancer treatment that they wish they'
FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T
Breakthrough brings potential glioblastoma drug into focus

Breakthrough brings potential glioblastoma drug into focus

byKeck School of Medicine of USCA new type of small molecule drug, the first to target circadian clock proteins as a way to treat glioblastoma, is now in phase 1 clinical trials. Credit: Issey T

Breakthrough brings potential glioblastoma drug into focus

byKeck School of Medicine of USCA new type of small molecule drug, the first to target circadian clock proteins as a way to treat glioblastoma, is now in phase 1 clinical trials. Credit: Issey T
Stopping the resistance of cancer cells to treatment

Stopping the resistance of cancer cells to treatment

by Colin Poitras,University of ConnecticutCredit: CC0 Public DomainOne of the drawbacks of chemotherapy is that cancer patients can build up resistance to treatment over time, increasing their c

Stopping the resistance of cancer cells to treatment

by Colin Poitras,University of ConnecticutCredit: CC0 Public DomainOne of the drawbacks of chemotherapy is that cancer patients can build up resistance to treatment over time, increasing their c
RNA-based therapy shows promise against aggressive childhood brain tumors in mice

RNA-based therapy shows promise against aggressive childhood brain tumors in mice

by Johns Hopkins UniversityCredit:Cell Reports(2024). DOI: 10.1016/j.celrep.2024.113938Targeting a non-encoding stretch of RNA may help shrink tumors caused by an aggressive type of b

RNA-based therapy shows promise against aggressive childhood brain tumors in mice

by Johns Hopkins UniversityCredit:Cell Reports(2024). DOI: 10.1016/j.celrep.2024.113938Targeting a non-encoding stretch of RNA may help shrink tumors caused by an aggressive type of b
Research: Subset of breast cancers have two PIK3CA mutations on the same allele

Research: Subset of breast cancers have two PIK3CA mutations on the same allele

by Bob Yirka , Medical XpressCredit: CC0 Public DomainA team of researchers affiliated with a large number of institutions in the U.S. has found that a subgroup of breast cancers have two PIK3CA mutat

Research: Subset of breast cancers have two PIK3CA mutations on the same allele

by Bob Yirka , Medical XpressCredit: CC0 Public DomainA team of researchers affiliated with a large number of institutions in the U.S. has found that a subgroup of breast cancers have two PIK3CA mutat
Vitamin A derivative selectively kills liver cancer stem cells

Vitamin A derivative selectively kills liver cancer stem cells

by RIKENRetinol or Vitamin A 3D space model (balls model). Credit: YassineMrabet, Wikipedia.Acyclic retinoid, an artificial compound derived from vitamin A, has been found to prevent the recurren

Vitamin A derivative selectively kills liver cancer stem cells

by RIKENRetinol or Vitamin A 3D space model (balls model). Credit: YassineMrabet, Wikipedia.Acyclic retinoid, an artificial compound derived from vitamin A, has been found to prevent the recurren
Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesPatient cells imaged by pharmacoscopy. Credit: CeMM/Gregory VladimerResearchers at CeMM and the Medical University of

Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesPatient cells imaged by pharmacoscopy. Credit: CeMM/Gregory VladimerResearchers at CeMM and the Medical University of